Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells

The advent of novel, innovative, and effective anti-cancer immunotherapies has engendered an era of renewed optimism among cancer specialists and their patients. Foremost among these successful immunotherapies are monoclonal antibodies (MAbs) which target immune checkpoint inhibitor (ICI) molecules,...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Ronald, Theron, Annette J., Rapoport, Bernardo L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775220/
https://www.ncbi.nlm.nih.gov/pubmed/31616428
http://dx.doi.org/10.3389/fimmu.2019.02254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775220/
https://www.ncbi.nlm.nih.gov/pubmed/31616428
http://dx.doi.org/10.3389/fimmu.2019.02254

Ejemplares similares